Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
C&F Financial | CFFI | Nov 20, 2024 | 74.48 | +0.62 |
C.H. Robinson Worldwide | CHRW | Nov 20, 2024 | 109.03 | -0.05 |
C3.ai | AI | Nov 20, 2024 | 32.36 | -1.82 |
C3is | CISS | Nov 20, 2024 | 0.82 | -16.32 |
C4 Therapeutics | CCCC | Nov 20, 2024 | 4.05 | -2.41 |
Cabaletta Bio | CABA | Nov 20, 2024 | 2.26 | -11.02 |
Cabana Target Drawdown 10 ETF | TDSC | Nov 20, 2024 | 25.60 | +0.31 |
Cabana Target Drawdown 7 ETF | TDSB | Nov 20, 2024 | 22.56 | +0.09 |
Cable One | CABO | Nov 20, 2024 | 403.37 | +1.31 |
Cabot | CBT | Nov 20, 2024 | 107.21 | -0.53 |
CACI International A | CACI | Nov 20, 2024 | 454.90 | +2.31 |
Cactus A | WHD | Nov 20, 2024 | 65.29 | +0.11 |
Cactus Acquisition 1 A | CCTS | Nov 20, 2024 | 11.65 | 0.00 |
Cadeler ADR | CDLR | Nov 20, 2024 | 23.76 | +0.55 |
Cadence Bank | CADE | Nov 20, 2024 | 37.11 | -0.56 |
Cadence Bank A | CADE-A | Nov 20, 2024 | 20.76 | -0.62 |
Cadence Design Systems | CDNS | Nov 20, 2024 | 304.01 | +1.46 |
Cadiz | CDZI | Nov 20, 2024 | 3.15 | -2.78 |
Cadiz Pref ADR | CDZIP | Nov 20, 2024 | 16.16 | +0.06 |
Cadre | CDRE | Nov 20, 2024 | 32.43 | +1.50 |
Cadrenal Therapeutics | CVKD | Nov 20, 2024 | 14.50 | -4.16 |
Cae | CAE | Nov 20, 2024 | 22.69 | +0.98 |
Caesars Entertainment | CZR | Nov 20, 2024 | 37.59 | +0.56 |
Caesarstone | CSTE | Nov 20, 2024 | 3.83 | -1.29 |
Cal-Maine Foods | CALM | Nov 20, 2024 | 94.78 | -0.38 |
Calamos Convertible High Fund | CHY | Nov 20, 2024 | 12.21 | +0.58 |
Calamos Convertible Opportunities And Income Fund | CHI | Nov 20, 2024 | 12.07 | +1.26 |
Calamos Dynamic Convertible & Income Fund | CCD | Nov 20, 2024 | 24.33 | +1.46 |
Calamos Global Dynamic Fund | CHW | Nov 20, 2024 | 6.96 | +0.29 |
Calamos Global Total Return Fund | CGO | Nov 20, 2024 | 11.72 | +0.69 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.